MetLife Investment Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Buy |
|
|||||
|
2025
Q1 | $267K | Sell |
|
|||||
|
2024
Q4 | $434K | Buy |
|
|||||
|
2024
Q3 | $424K | Hold |
|
|||||
|
2024
Q2 | $420K | Sell |
|
|||||
|
2024
Q1 | $552K | Hold |
|
|||||
|
2023
Q4 | $488K | Hold |
|
|||||
|
2023
Q3 | $410K | Buy |
|
|||||
|
2023
Q2 | $315K | Buy |
|
|||||
|
2023
Q1 | $208K | Hold |
|
|||||
|
2022
Q4 | $335K | Hold |
|
|||||
|
2022
Q3 | $312K | Hold |
|
|||||
|
2022
Q2 | $279K | Hold |
|
|||||
|
2022
Q1 | $154K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $114K | Buy |
|